Prevention of gallstones by Lidan Granule: Insight into underlying mechanisms using a guinea pig model

Wu,Xiao; Liang,Xiaoqiang; Du,Yijie; Zhang,Yan; Yang,Meng; Gong,Weiyi; Liu,Baojun; Dong,Jingcheng; Zhang,Ningxia; Zhang,Hongying

doi:10.3892/br.2016.672

Prevention of gallstones by Lidan Granule: Insight into underlying mechanisms using a guinea pig model

Authors:
- Xiao Wu
- Xiaoqiang Liang
- Yijie Du
- Yan Zhang
- Meng Yang
- Weiyi Gong
- Baojun Liu
- Jingcheng Dong
- Ningxia Zhang
- Hongying Zhang
View Affiliations

Affiliations: Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, P.R. China, General Surgery, Dong'e People's Hospital, Liaocheng, Shandong 252200, P.R. China, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, P.R. China
Published online on: May 6, 2016 https://doi.org/10.3892/br.2016.672
Pages: 50-56
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the study was to examine the mechanism of action of Lidan Granule (LDG) for the prevention of gallstones using a guinea pig model. One hundred guinea pigs were divided into five groups randomly: control (standard diet and saline), model [lithogenic diet (LD) and saline], LDG-H (LD and 2 g/kg of LDG), LDG-L (LD and 1 g/kg of LDG), and ursodeoxycholic acid (UDCA) (LD and UDCA) as the positive control. At 6 weeks, the rate of gallstone formation and weight of the adrenal gland were recorded and serum levels of inflammatory cytokines were measured. Levels of corticotrophin-releasing hormone (CRH) in the hypothalamus, adrenocorticotropic hormone (ACTH) in the hypophysis, and serum cortisol were determined. Bile components were tested with colorimetry. At 6 weeks, the rate of gallstone formation was significantly decreased in the LDG-H (14.29%) and LDG-L (21.43%) groups compared to the model group (81.25%; P<0.01). LDG treatment decreased the serum levels of interleukin (IL)-1, IL-6, and tumor necrosis factor-α (P<0.01). LDG decreased bile cholesterol and increased bile acid and phospholipid levels in the bile (P<0.01). LDG treatment recovered the function of the hypothalamic-pituitary-adrenal (HPA) axis by increasing the expression of CRH (P<0.01) and ACTH (P<0.05). LDG made the bile less lithogenic, improved the function of the HPA axis, and regulated the expression of inflammatory cytokines for the prevention of cholelithiasis.

View Figures

View References

1	Erichsen R, Frøslev T, Lash TL, Pedersen L and Sørensen HT: Long-term statin use and the risk of gallstone disease: a population-based case-control study. Am J Epidemiol. 173:162–170. 2011. View Article : Google Scholar : PubMed/NCBI
2	Stinton LM and Shaffer EA: Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 6:172–187. 2012. View Article : Google Scholar : PubMed/NCBI
3	Markar SR, Karthikesalingam A, Thrumurthy S, Muirhead L, Kinross J and Paraskeva P: Single-incision laparoscopic surgery (SILS) vs. conventional multiport cholecystectomy: systematic review and meta-analysis. Surg Endosc. 26:1205–1213. 2012. View Article : Google Scholar : PubMed/NCBI
4	Zhang SB and Fang BJ: Effects of Yanggan Lidan Granule on rate of gallstone formation and content of plasma cholecystokinin in guinea pigs with induced cholesterol gallstones. Zhong Xi Yi Jie He Xue Bao. 6:405–408. 2008.(In Chinese). View Article : Google Scholar : PubMed/NCBI
5	Mann KS, Welfare E, Hughes D, et al: Significant service reconfiguration is required to definitively treat gallstone pancreatitis and prevent serious complications. Br J Surg. 99:164–165. 2012.PubMed/NCBI
6	Smelt AH: Triglycerides and gallstone formation. Clin Chim Acta. 411:1625–1631. 2010. View Article : Google Scholar : PubMed/NCBI
7	You SF, Zheng PY, Ji G, Wei HF, Zhao J and Zhu PT: Protective effects of yanggan lidan granules on carbon tetrachloride-induced liver damage in mice. Zhong Xi Yi Jie He Xue Bao. 3:470–472. 2005.(In Chinese). View Article : Google Scholar : PubMed/NCBI
8	Wang SN, Yeh YT, Wang ST, Chuang SC, Wang CL, Yu ML and Lee KT: Visfatin - a proinflammatory adipokine-in gallstone disease. Am J Surg. 199:459–465. 2010. View Article : Google Scholar : PubMed/NCBI
9	Maurer KJ, Carey MC and Fox JG: Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology. 136:425–440. 2009. View Article : Google Scholar : PubMed/NCBI
10	Kasprzak A, Szmyt M, Malkowski W, Przybyszewska W, Helak-Łapaj C, Seraszek-Jaros A, Surdacka A, Małkowska-Lanzafame A and Kaczmarek E: Analysis of immunohistochemical expression of proinflammatory cytokines (IL-1α, IL-6, and TNF-α) in gallbladder mucosa: Comparative study in acute and chronic calculous cholecystitis. Folia Morphol (Warsz). 74:65–72. 2015. View Article : Google Scholar : PubMed/NCBI
11	Chai J, He Y, Cai SY, Jiang Z, Wang H, Li Q, Chen L, Peng Z, He X, Wu X, et al: Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway. Hepatology. 55:1485–1494. 2012. View Article : Google Scholar : PubMed/NCBI
12	McNeilly AD, Macfarlane DP, O'Flaherty E, Livingstone DE, Mitić T, McConnell KM, McKenzie SM, Davies E, Reynolds RM, Thiesson HC, et al: Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol. 52:705–711. 2010. View Article : Google Scholar : PubMed/NCBI
13	Soliman HM, Abd El-Haleem MR and El Tarhouny SA: Histomorphometrical and Electron Microscopic Study of Adrenocorticocytes Following Surgically Induced Extrahepatic Biliary Obstruction in Adult Female Albino Rats: Histomorphometrical and electron microscopic study of adrenocorticocytes following surgically induced extrahepatic biliary obstruction in adult female albino rats. Folia Biol (Praha). 61:14–25. 2015.PubMed/NCBI
14	Rose AJ, Berriel Díaz M, Reimann A, Klement J, Walcher T, Krones-Herzig A, Strobel O, Werner J, Peters A, Kleyman A, et al: Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metab. 14:123–130. 2011. View Article : Google Scholar : PubMed/NCBI
15	Xiang Y, Chen JH, Cai D and Ma BJ: Effect of Lidan Granule on bile lithogenesis in patients with choledocholithiasis combined with cholecystolithiasis. Chin J Integr Med. 14:142–144. 2008. View Article : Google Scholar : PubMed/NCBI
16	Zuo YT, Gao WY, Jia W, Duan HQ and Xiao PG: Prevention and treatment of cholelithiasis by traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 29:831–833, 910. 2004.(In Chinese). PubMed/NCBI
17	Wang HH, Portincasa P, Mendez-Sanchez N, Uribe M and Wang DQ: Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology. 134:2101–2110. 2008. View Article : Google Scholar : PubMed/NCBI
18	Song XY, Xu S, Hu JF, Tang J, Chu SF, Liu H, Han N, Li JW, Zhang DM, Li YT, et al: Piperine prevents cholesterol gallstones formation in mice. Eur J Pharmacol. 751:112–117. 2015. View Article : Google Scholar : PubMed/NCBI
19	Alonso R, Griebel G, Pavone G, Stemmelin J, Le Fur G and Soubrié P: Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Mol Psychiatry. 9:278–286, 224. 2004. View Article : Google Scholar : PubMed/NCBI
20	Zhu L, Aili A, Zhang C, Saiding A and Abudureyimu K: Prevalence of and risk factors for gallstones in Uighur and Han Chinese. World J Gastroenterol. 20:14942–14949. 2014. View Article : Google Scholar : PubMed/NCBI
21	Wittenburg H: Hereditary liver disease: gallstones. Best Pract Res Clin Gastroenterol. 24:747–756. 2010. View Article : Google Scholar : PubMed/NCBI
22	Méndez-Sánchez N, Zamora-Valdés D, Chávez-Tapia NC and Uribe M: Role of diet in cholesterol gallstone formation. Clin Chim Acta. 376:1–8. 2007. View Article : Google Scholar : PubMed/NCBI
23	Fang BJ, Zhou S, Pei XJ, Huang JY, Chen BJ, Geng Y and Yang LK: Effects of Yanggan Lidan Granule on insulin resistance in guinea pigs with induced cholesterol gallstones. Zhong Xi Yi Jie He Xue Bao. 7:1159–1163. 2009.(In Chinese). View Article : Google Scholar : PubMed/NCBI
24	No authors listed: Current bibliographies of neuropeptides prepared by the University of Sheffield Biomedical Information Service. Neuropeptides. 29:B37–B49. 1995.PubMed/NCBI
25	Yun JW, Kim JS, Choi WS, et al: Inhibition of sphingolipid pathway affects the formation of cholesterol gallstone by the modulation of Il-6/Stat3 pathway in mice model. J Gastroenterol Hepatol. 27:85–86. 2012.PubMed/NCBI
26	Rosenblat JD, Cha DS, Mansur RB and McIntyre RS: Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 53:23–34. 2014. View Article : Google Scholar : PubMed/NCBI
27	Peng Y, Yang Y, Liu Y, Nie Y, Xu P, Xia B, Tian F and Sun Q: Cholesterol gallstones and bile host diverse bacterial communities with potential to promote the formation of gallstones. Microb Pathog. 83–84:57–63. 2015. View Article : Google Scholar
28	Halilbasic E, Claudel T and Trauner M: Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol. 58:155–168. 2013. View Article : Google Scholar : PubMed/NCBI